T790M inhibitor as first line therapy: Promises and pitfalls

Date 13 April 2016
Event European Lung Cancer Conference 2016 (ELCC) 2016
Session Targeting T790M
Topics Anti-Cancer Agents & Biologic Therapy
Non-Small-Cell Lung Cancer, Metastatic
Translational Research
Presenter David Planchard
Authors D. Planchard
  • Gustave Roussy Institut, Villejuif/FR